TY - JOUR AU - Ferlay, J. AU - Shin, H. R. AU - Bray, F. AU - Forman, D. AU - Mathers, C. AU - Parkin, D. M. PY - 2010 DA - 2010// TI - Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 JO - Int J Cancer VL - 127 UR - https://doi.org/10.1002/ijc.25516 DO - 10.1002/ijc.25516 ID - Ferlay2010 ER - TY - JOUR AU - Payne, S. J. AU - Bowen, R. L. AU - Jones, J. L. AU - Wells, C. A. PY - 2008 DA - 2008// TI - Predictive markers in breast cancer–the present JO - Histopathology VL - 52 UR - https://doi.org/10.1111/j.1365-2559.2007.02897.x DO - 10.1111/j.1365-2559.2007.02897.x ID - Payne2008 ER - TY - JOUR AU - Cserni, G. AU - Francz, M. AU - Jaray, B. AU - Kalman, E. AU - Kovacs, I. AU - Kulka, J. AU - Orosz, Z. AU - Udvarhelyi, N. AU - Vass, L. PY - 2010 DA - 2010// TI - Pathologic diagnosis and histopathology record of breast cancer JO - Magy Onkol VL - 54 UR - https://doi.org/10.1556/MOnkol.54.2010.3.3 DO - 10.1556/MOnkol.54.2010.3.3 ID - Cserni2010 ER - TY - JOUR AU - Kuroi, K. AU - Toi, M. AU - Tsuda, H. AU - Kurosumi, M. AU - Akiyama, F. PY - 2006 DA - 2006// TI - Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer JO - Breast Cancer VL - 13 UR - https://doi.org/10.2325/jbcs.13.38 DO - 10.2325/jbcs.13.38 ID - Kuroi2006 ER - TY - JOUR AU - Mittendorf, E. A. AU - Jeruss, J. S. AU - Tucker, S. L. AU - Kolli, A. AU - Newman, L. A. AU - Gonzalez-Angulo, A. M. AU - Buchholz, T. A. AU - Sahin, A. A. AU - Cormier, J. N. AU - Buzdar, A. U. PY - 2011 DA - 2011// TI - Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.31.8469 DO - 10.1200/JCO.2010.31.8469 ID - Mittendorf2011 ER - TY - JOUR AU - Sahoo, S. AU - Lester, S. C. PY - 2009 DA - 2009// TI - Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting JO - Arch Pathol Lab Med VL - 133 ID - Sahoo2009 ER - TY - JOUR AU - Shien, T. AU - Shimizu, C. AU - Seki, K. AU - Shibata, T. AU - Hojo, T. AU - Ando, M. AU - Kohno, T. AU - Katsumata, N. AU - Akashi-Tanaka, S. AU - Kinoshita, T. PY - 2009 DA - 2009// TI - Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome JO - Breast Cancer Res Treat VL - 113 UR - https://doi.org/10.1007/s10549-008-9935-2 DO - 10.1007/s10549-008-9935-2 ID - Shien2009 ER - TY - JOUR AU - Jeruss, J. S. AU - Mittendorf, E. A. AU - Tucker, S. L. AU - Gonzalez-Angulo, A. M. AU - Buchholz, T. A. AU - Sahin, A. A. AU - Cormier, J. N. AU - Buzdar, A. U. AU - Hortobagyi, G. N. AU - Hunt, K. K. PY - 2008 DA - 2008// TI - Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.11.5352 DO - 10.1200/JCO.2007.11.5352 ID - Jeruss2008 ER - TY - JOUR AU - Jeruss, J. S. AU - Mittendorf, E. A. AU - Tucker, S. L. AU - Gonzalez-Angulo, A. M. AU - Buchholz, T. A. AU - Sahin, A. A. AU - Cormier, J. N. AU - Buzdar, A. U. AU - Hortobagyi, G. N. AU - Hunt, K. K. PY - 2008 DA - 2008// TI - Staging of breast cancer in the neoadjuvant setting JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6520 DO - 10.1158/0008-5472.CAN-07-6520 ID - Jeruss2008 ER - TY - JOUR AU - Czyz, J. PY - 2008 DA - 2008// TI - The stage-specific function of gap junctions during tumourigenesis JO - Cell Mol Biol Lett VL - 13 UR - https://doi.org/10.2478/s11658-007-0039-5 DO - 10.2478/s11658-007-0039-5 ID - Czyz2008 ER - TY - JOUR AU - Goodenough, D. A. AU - Paul, D. L. PY - 2009 DA - 2009// TI - Gap junctions JO - Cold Spring Harb Perspect Biol VL - 1 UR - https://doi.org/10.1101/cshperspect.a002576 DO - 10.1101/cshperspect.a002576 ID - Goodenough2009 ER - TY - JOUR AU - Vinken, M. AU - Vanhaecke, T. AU - Papeleu, P. AU - Snykers, S. AU - Henkens, T. AU - Rogiers, V. PY - 2006 DA - 2006// TI - Connexins and their channels in cell growth and cell death JO - Cell Signal VL - 18 UR - https://doi.org/10.1016/j.cellsig.2005.08.012 DO - 10.1016/j.cellsig.2005.08.012 ID - Vinken2006 ER - TY - JOUR AU - Rackauskas, M. AU - Neverauskas, V. AU - Skeberdis, V. A. PY - 2010 DA - 2010// TI - Diversity and properties of connexin gap junction channels JO - Medicina (Kaunas) VL - 46 ID - Rackauskas2010 ER - TY - JOUR AU - Houghton, F. D. PY - 2005 DA - 2005// TI - Role of gap junctions during early embryo development JO - Reproduction VL - 129 UR - https://doi.org/10.1530/rep.1.00277 DO - 10.1530/rep.1.00277 ID - Houghton2005 ER - TY - JOUR AU - Krysko, D. V. AU - Leybaert, L. AU - Vandenabeele, P. AU - D'Herde, K. PY - 2005 DA - 2005// TI - Gap junctions and the propagation of cell survival and cell death signals JO - Apoptosis VL - 10 UR - https://doi.org/10.1007/s10495-005-1875-2 DO - 10.1007/s10495-005-1875-2 ID - Krysko2005 ER - TY - JOUR AU - Herve, J. C. AU - Derangeon, M. AU - Sarrouilhe, D. AU - Giepmans, B. N. AU - Bourmeyster, N. PY - 2012 DA - 2012// TI - Gap junctional channels are parts of multiprotein complexes JO - Biochim Biophys Acta VL - 1818 UR - https://doi.org/10.1016/j.bbamem.2011.12.009 DO - 10.1016/j.bbamem.2011.12.009 ID - Herve2012 ER - TY - JOUR AU - Locke, D. PY - 1998 DA - 1998// TI - Gap junctions in normal and neoplastic mammary gland JO - J Pathol VL - 186 UR - https://doi.org/3.0.CO;2-X DO - 3.0.CO;2-X ID - Locke1998 ER - TY - JOUR AU - Pointis, G. AU - Fiorini, C. AU - Gilleron, J. AU - Carette, D. AU - Segretain, D. PY - 2007 DA - 2007// TI - Connexins as precocious markers and molecular targets for chemical and pharmacological agents in carcinogenesis JO - Curr Med Chem VL - 14 UR - https://doi.org/10.2174/092986707781696564 DO - 10.2174/092986707781696564 ID - Pointis2007 ER - TY - JOUR AU - Cronier, L. AU - Crespin, S. AU - Strale, P. O. AU - Defamie, N. AU - Mesnil, M. PY - 2009 DA - 2009// TI - Gap junctions and cancer: new functions for an old story JO - Antioxid Redox Signal VL - 11 UR - https://doi.org/10.1089/ars.2008.2153 DO - 10.1089/ars.2008.2153 ID - Cronier2009 ER - TY - JOUR AU - Oviedo-Orta, E. AU - Errington, R. J. AU - Evans, W. H. PY - 2002 DA - 2002// TI - Gap junction intercellular communication during lymphocyte transendothelial migration JO - Cell Biol Int VL - 26 UR - https://doi.org/10.1006/cbir.2001.0840 DO - 10.1006/cbir.2001.0840 ID - Oviedo-Orta2002 ER - TY - JOUR AU - Kanczuga-Koda, L. AU - Sulkowska, M. AU - Koda, M. AU - Rutkowski, R. AU - Sulkowski, S. PY - 2007 DA - 2007// TI - Increased expression of gap junction protein–connexin 32 in lymph node metastases of human ductal breast cancer JO - Folia Histochem Cytobiol VL - 45 ID - Kanczuga-Koda2007 ER - TY - JOUR AU - Kanczuga-Koda, L. AU - Sulkowski, S. AU - Lenczewski, A. AU - Koda, M. AU - Wincewicz, A. AU - Baltaziak, M. AU - Sulkowska, M. PY - 2006 DA - 2006// TI - Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer JO - J Clin Pathol VL - 59 UR - https://doi.org/10.1136/jcp.2005.029272 DO - 10.1136/jcp.2005.029272 ID - Kanczuga-Koda2006 ER - TY - JOUR AU - McLachlan, E. AU - Shao, Q. AU - Laird, D. W. PY - 2007 DA - 2007// TI - Connexins and gap junctions in mammary gland development and breast cancer progression JO - J Membr Biol VL - 218 UR - https://doi.org/10.1007/s00232-007-9052-x DO - 10.1007/s00232-007-9052-x ID - McLachlan2007 ER - TY - JOUR AU - Banerjee, D. AU - Gakhar, G. AU - Madgwick, D. AU - Hurt, A. AU - Takemoto, D. AU - Nguyen, T. A. PY - 2010 DA - 2010// TI - A novel role of gap junction connexin46 protein to protect breast tumours from hypoxia JO - Int J Cancer VL - 127 ID - Banerjee2010 ER - TY - BOOK AU - Fattaneh, A. AU - Tavassoli, P. D. PY - 2003 DA - 2003// TI - WHO Series, Tumours of the Breast and Female Genital Organs ID - Fattaneh2003 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Schwartz, J. N. AU - Hagerty, K. L. AU - Allred, D. C. AU - Cote, R. J. AU - Dowsett, M. AU - Fitzgibbons, P. L. AU - Hanna, W. M. AU - Langer, A. PY - 2007 DA - 2007// TI - American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.2775 DO - 10.1200/JCO.2006.09.2775 ID - Wolff2007 ER - TY - JOUR AU - Kononen, J. AU - Bubendorf, L. AU - Kallioniemi, A. AU - Barlund, M. AU - Schraml, P. AU - Leighton, S. AU - Torhorst, J. AU - Mihatsch, M. J. AU - Sauter, G. AU - Kallioniemi, O. P. PY - 1998 DA - 1998// TI - Tissue microarrays for high-throughput molecular profiling of tumour specimens JO - Nat Med VL - 4 UR - https://doi.org/10.1038/nm0798-844 DO - 10.1038/nm0798-844 ID - Kononen1998 ER - TY - JOUR AU - Theurillat, J. P. AU - Zurrer-Hardi, U. AU - Varga, Z. AU - Barghorn, A. AU - Saller, E. AU - Frei, C. AU - Storz, M. AU - Behnke, S. AU - Seifert, B. AU - Fehr, M. PY - 2008 DA - 2008// TI - Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts JO - Int J Cancer VL - 122 UR - https://doi.org/10.1002/ijc.23241 DO - 10.1002/ijc.23241 ID - Theurillat2008 ER - TY - JOUR AU - Sohl, G. AU - Willecke, K. PY - 2004 DA - 2004// TI - Gap junctions and the connexin protein family JO - Cardiovasc Res VL - 62 UR - https://doi.org/10.1016/j.cardiores.2003.11.013 DO - 10.1016/j.cardiores.2003.11.013 ID - Sohl2004 ER - TY - JOUR AU - Krenacs, T. AU - Ficsor, L. AU - Varga, S. V. AU - Angeli, V. AU - Molnar, B. PY - 2010 DA - 2010// TI - Digital microscopy for boosting database integration and analysis in TMA studies JO - Methods in molecular biology (Clifton, NJ) VL - 664 UR - https://doi.org/10.1007/978-1-60761-806-5_16 DO - 10.1007/978-1-60761-806-5_16 ID - Krenacs2010 ER - TY - JOUR AU - Miglietta, L. AU - Vanella, P. AU - Canobbio, L. AU - Naso, C. AU - Cerisola, N. AU - Meszaros, P. AU - Parodi, M. A. AU - Morabito, F. PY - 2010 DA - 2010// TI - Prognostic value of estrogen receptor and Ki-67 index after neoadjuvant chemotherapy in locally advanced breast cancer expressing high levels of proliferation at diagnosis JO - Oncology VL - 79 UR - https://doi.org/10.1159/000322189 DO - 10.1159/000322189 ID - Miglietta2010 ER - TY - JOUR AU - Kyo, N. AU - Yamamoto, H. AU - Takeda, Y. AU - Ezumi, K. AU - Ngan, C. Y. AU - Terayama, M. AU - Miyake, M. AU - Takemasa, I. AU - Ikeda, M. AU - Doki, Y. PY - 2008 DA - 2008// TI - Overexpression of connexin 26 in carcinoma of the pancreas JO - Oncol Rep VL - 19 ID - Kyo2008 ER - TY - JOUR AU - Tate, A. W. AU - Lung, T. AU - Radhakrishnan, A. AU - Lim, S. D. AU - Lin, X. AU - Edlund, M. PY - 2006 DA - 2006// TI - Changes in gap junctional connexin isoforms during prostate cancer progression JO - Prostate VL - 66 UR - https://doi.org/10.1002/pros.20317 DO - 10.1002/pros.20317 ID - Tate2006 ER - TY - JOUR AU - Liu, X. AU - Furuya, T. AU - Li, D. AU - Xu, J. AU - Cao, X. AU - Li, Q. AU - Xu, Z. AU - Sasaki, K. PY - 2010 DA - 2010// TI - Connexin 26 expression correlates with less aggressive phenotype of intestinal type-gastric carcinomas JO - Int J Mol Med VL - 25 UR - https://doi.org/10.3892/ijmm_00000395 DO - 10.3892/ijmm_00000395 ID - Liu2010 ER - TY - JOUR AU - Nomura, S. AU - Maeda, K. AU - Noda, E. AU - Inoue, T. AU - Fukunaga, S. AU - Nagahara, H. AU - Hirakawa, K. PY - 2010 DA - 2010// TI - Clinical significance of the expression of connexin26 in colorectal cancer JO - J Exp Clin Cancer Res VL - 29 UR - https://doi.org/10.1186/1756-9966-29-79 DO - 10.1186/1756-9966-29-79 ID - Nomura2010 ER - TY - JOUR AU - Bier, A. AU - Oviedo-Landaverde, I. AU - Zhao, J. AU - Mamane, Y. AU - Kandouz, M. AU - Batist, G. PY - 2009 DA - 2009// TI - Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target JO - Mol Cancer Ther VL - 8 UR - https://doi.org/10.1158/1535-7163.MCT-08-0930 DO - 10.1158/1535-7163.MCT-08-0930 ID - Bier2009 ER - TY - JOUR AU - Kamei, J. AU - Toyofuku, T. AU - Hori, M. PY - 2003 DA - 2003// TI - Negative regulation of p21 by beta-catenin/TCF signaling: a novel mechanism by which cell adhesion molecules regulate cell proliferation JO - Biochem Biophys Res Commun VL - 312 UR - https://doi.org/10.1016/j.bbrc.2003.10.129 DO - 10.1016/j.bbrc.2003.10.129 ID - Kamei2003 ER - TY - JOUR AU - Lee, S. W. AU - Tomasetto, C. AU - Paul, D. AU - Keyomarsi, K. AU - Sager, R. PY - 1992 DA - 1992// TI - Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumour cell lines JO - J Cell Biol VL - 118 UR - https://doi.org/10.1083/jcb.118.5.1213 DO - 10.1083/jcb.118.5.1213 ID - Lee1992 ER - TY - JOUR AU - Conklin, C. AU - Huntsman, D. AU - Yorida, E. AU - Makretsov, N. AU - Turbin, D. AU - Bechberger, J. F. AU - Sin, W. C. AU - Naus, C. C. PY - 2007 DA - 2007// TI - Tissue microarray analysis of connexin expression and its prognostic significance in human breast cancer JO - Cancer Lett VL - 255 UR - https://doi.org/10.1016/j.canlet.2007.05.001 DO - 10.1016/j.canlet.2007.05.001 ID - Conklin2007 ER - TY - JOUR AU - Kulka, J. AU - Tokes, A. M. AU - Toth, A. I. AU - Szasz, A. M. AU - Farkas, A. AU - Borka, K. AU - Jaray, B. AU - Szekely, E. AU - Istok, R. AU - Lotz, G. PY - 2009 DA - 2009// TI - Immunohistochemical phenotype of breast carcinomas predicts the effectiveness of primary systemic therapy JO - Magy Onkol VL - 53 UR - https://doi.org/10.1556/MOnkol.53.2009.4.2 DO - 10.1556/MOnkol.53.2009.4.2 ID - Kulka2009 ER - TY - JOUR AU - Neubauer, H. AU - Gall, C. AU - Vogel, U. AU - Hornung, R. AU - Wallwiener, D. AU - Solomayer, E. AU - Fehm, T. PY - 2008 DA - 2008// TI - Changes in tumour biological markers during primary systemic chemotherapy (PST) JO - Anticancer Res VL - 28 ID - Neubauer2008 ER - TY - JOUR AU - van de Ven, S. AU - Smit, V. T. AU - Dekker, T. J. AU - Nortier, J. W. AU - Kroep, J. R. PY - 2011 DA - 2011// TI - Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer JO - Cancer Treat Rev VL - 37 ID - van de Ven2011 ER - TY - JOUR AU - Varga, Z. AU - Caduff, R. AU - Pestalozzi, B. PY - 2005 DA - 2005// TI - Stability of the HER2 gene after primary chemotherapy in advanced breast cancer JO - Virchows Arch VL - 446 UR - https://doi.org/10.1007/s00428-004-1164-4 DO - 10.1007/s00428-004-1164-4 ID - Varga2005 ER - TY - JOUR AU - Darb-Esfahani, S. AU - Loibl, S. AU - Muller, B. M. AU - Roller, M. AU - Denkert, C. AU - Komor, M. AU - Schluns, K. AU - Blohmer, J. U. AU - Budczies, J. AU - Gerber, B. PY - 2009 DA - 2009// TI - Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy JO - Breast Cancer Res VL - 11 UR - https://doi.org/10.1186/bcr2363 DO - 10.1186/bcr2363 ID - Darb-Esfahani2009 ER - TY - JOUR AU - Denkert, C. AU - Sinn, B. V. AU - Issa, Y. AU - Maria Muller, B. AU - Maisch, A. AU - Untch, M. AU - von Minckwitz, G. AU - Loibl, S. PY - 2011 DA - 2011// TI - Prediction of Response to Neoadjuvant Chemotherapy: New Biomarker Approaches and Concepts JO - Breast Care (Basel) VL - 6 ID - Denkert2011 ER - TY - JOUR AU - Guiu, S. AU - Gauthier, M. AU - Coudert, B. AU - Bonnetain, F. AU - Favier, L. AU - Ladoire, S. AU - Tixier, H. AU - Guiu, B. AU - Penault-Llorca, F. AU - Ettore, F. PY - 2010 DA - 2010// TI - Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer JO - Br J Cancer VL - 103 UR - https://doi.org/10.1038/sj.bjc.6605939 DO - 10.1038/sj.bjc.6605939 ID - Guiu2010 ER - TY - JOUR AU - Precht, L. M. AU - Lowe, K. A. AU - Atwood, M. AU - Beatty, J. D. PY - 2010 DA - 2010// TI - Neoadjuvant chemotherapy of breast cancer: tumour markers as predictors of pathologic response, recurrence, and survival JO - Breast J VL - 16 ID - Precht2010 ER - TY - JOUR AU - Untch, M. AU - Fasching, P. A. AU - Konecny, G. E. AU - Hasmuller, S. AU - Lebeau, A. AU - Kreienberg, R. AU - Camara, O. AU - Muller, V. AU - du Bois, A. AU - Kuhn, T. PY - 2011 DA - 2011// TI - Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.31.4930 DO - 10.1200/JCO.2010.31.4930 ID - Untch2011 ER - TY - JOUR AU - von Minckwitz, G. AU - Sinn, H. P. AU - Raab, G. AU - Loibl, S. AU - Blohmer, J. U. AU - Eidtmann, H. AU - Hilfrich, J. AU - Merkle, E. AU - Jackisch, C. AU - Costa, S. D. PY - 2008 DA - 2008// TI - Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast JO - Breast Cancer Res VL - 10 UR - https://doi.org/10.1186/bcr1989 DO - 10.1186/bcr1989 ID - von Minckwitz2008 ER - TY - JOUR AU - Osako, T. AU - Horii, R. AU - Matsuura, M. AU - Ogiya, A. AU - Domoto, K. AU - Miyagi, Y. AU - Takahashi, S. AU - Ito, Y. AU - Iwase, T. AU - Akiyama, F. PY - 2010 DA - 2010// TI - Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy JO - J Cancer Res Clin Oncol VL - 136 UR - https://doi.org/10.1007/s00432-009-0654-9 DO - 10.1007/s00432-009-0654-9 ID - Osako2010 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/13/50/prepub UR - http://www.biomedcentral.com/1471-2407/13/50/prepub ID - ref51 ER -